Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease

Experimental Biology and Medicine

Volumn 233, Issue 8, 2008, Pages 952-957

  Gattone II, Vincent H ^a   Siqueira Jr , Tibério M ^a,c   Powell, Charles R ^a,d   Trambaugh, Chad M ^a   Lingeman, James E ^a   Shalhav, Arieh L ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Orthopaedia and Traumatology Group (GOT)   (Brazil)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cy + rat; Denervation; Hypertension; Polycystic kidney disease

Indexed keywords

ALCOHOL;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; DISEASE COURSE; FLANK PAIN; HETEROZYGOTE; HISTOPATHOLOGY; HYPERTENSION; KIDNEY DENERVATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY INNERVATION; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; LAPAROTOMY; MALE; NONHUMAN; PROGENY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHAM PROCEDURE; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; ANIMAL; DENERVATION; FEMALE; INNERVATION; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT STRAIN; RENOVASCULAR HYPERTENSION;

ANIMALIA; RATTUS; RODENTIA;

ANIMALS; DENERVATION; FEMALE; HETEROZYGOTE; HYPERTENSION, RENAL; KIDNEY; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RATS; RATS, MUTANT STRAINS; RENIN-ANGIOTENSIN SYSTEM;

EID: 50649100435     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0802-RM-54     Document Type: Article

References (42)

1. Bajwa ZH, Sial KA, Malik AB, Steinman TI. Pain patterns in patients with polycystic kidney disease. Kidney Int 66:1561-1569, 2001.
2. Bajwa ZH, Gupta S, Warfield CA, Steinman TI. Pain management in polycystic kidney disease. Kidney Int 60:163-1644, 2001.
3. Elzinga LW, Barry JM, Torres VE, Zincke H, Warmer HW, Swan S, Bennett WM. Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2:1219-1226, 1992.
4. He SZ, An SY, Jiang HM, Yang R, Cao YF. Cyst decapitating decompression operation in polycystic kidney: preliminary report of 52 cases. Chin Med J 93:773-778, 1980.
5. Zheng K, Zhao Z, Wu Z. Analysis of 35 cases of polycystic kidneys. Chung Hua Niao Wai Ko Tsa Chih 3:99-100, 1982.
6. Wyss JM, Oparil S, Sripairojthikoon W. Neuronal control of the kidney: contribution to hypertension. Can J Physiol Pharmacol 70:759-770, 1992.
7. Katholi RE. Renal nerves and hypertension: an update. Fed Proc 44: 2846-2850, 1985.
8. Oparil S, Sripairojthikoon W, Wyss JM. The renal afferent nerves in the pathogenesis of hypertension. Can J Physiol Pharmacol 65:1548-1558, 1987.
9. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 12:2427-2433, 2001.
10. Badani KK, Hemal AK, Menon M. Autosomal dominant polycystic kidney disease and pain-a review of the disease from aetiology, evaluation, past surgical treatment options to current practice. J Postgrad Med 50:222-226, 2004.
11. Resnick M, Change AY Casale P. Laparoscopic renal denervation and nephropexy for autosomal dominant polycystic kidney disease related pain in adolescents. J Urol 175:2274-2276, 2006.
12. Sockeel P, Chapuis O, Pallas G, Pons F, Jancovici R. Thoracoscopic renal denervation for intractable autosomal dominant polycystic kidney disease-related pain. Am J Kidney Dis 43:161-163, 2004.
13. Kopp UC. Renorenal reflexes: interaction between efferent and afferent renal nerve activity. Can J Physiol Pharmacol 70:750-758, 1992.
14. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 77:75-197, 1997.
15. Phillips JK. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin Exp Pharmacol Physiol 32:415-418, 2005.
16. Cowley BD Jr, Gudapaty S, Kraybill AL, Barash BD, Harding MA, Calvet JP, Gattone VH. Autosomal-dominant polycystic kidney disease in the rat. Kidney Int 43:522-534, 1993.
17. Gattone VH, Shattuck M, Luft FC, Overhage JM, Willis LR, Evan AP. Effect of denervation on the afferent arteriole in the SHR. Jpn Heart J 25:745-753, 1984.
18. Gattone VH, Cowley BD, Barash BD, Nagao S, Takahashi H, Yamaguchi T, Grantham JJ. Methylprednisolone retards the progres-sion of inherited polycystic kidney disease in rodents. Am J Kidney Dis 25:302-313, 1995.
19. Nyengaard JR. Stereologic methods and their application in kidney research. J Am Soc Nephrol 10:1100-1123, 1999.
20. Gattone VH, Evan AP, Overhage JM, Severs WB. Developing renal innervation in the spontaneously hypertensive rat: evidence fora role of the sympathetic nervous system in renal damage. J Hypertens 8:423-428, 1990.
21. Holmer S, Rinne B, Eckardt KU, Le Hir M, Schricker K, Kaissling B, Riegger G, Kurtz A. Role of renal nerves for the expression of renin in adult rat kidney. Am J Physiol 266:F738-745, 1994.
22. Hendel MD, Collister JP. Renal denervation attenuates long-term hypertensive effects of Angiotensin ii in the rat. Clin Exp Pharmacol Physiol 33:1225-1230, 2006.
23. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin- angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323:1091-1096, 1990.
24. Loghman-Adham M, Soto CE, Inagami T, Cassis L. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol 287:F775-788, 2004.
25. Cerasola G, Li Vecchi M, Mulé G, Cottone S, Mangano MT, Andronico G, Contomo A, Parrino IA, Renda F, Pavone G, Scialabba A. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease. Contrib Nephrol 122:22-27, 1997.
26. Keith DS, Torres VE, Johnson CM, Holley KE. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats. Am J Kidney Dis 24:491-498 1994.
27. Ogborn MR, Sareen S, Pinette G. Cilazapril delays progression of hypertension and uremia in rat polycystic kidney disease. Am J Kid Dis 26:942-946, 1995.
28. el-Dahr SS, Gomez RA, Gray MS, Peach MJ, Carey RM, Chevalier RL. Renal nerves modulate renin gene expression in the developing rat kidney with ureteral obstruction. J Clin Invest 87:800-810, 1991.
29. Pupilli C, Gomez RA, Tuttle JB, Peach MJ, Carey RM. Spatial association of renin-containing cells and nerve fibers in developing rat kidney. Pediatr Nephrol 5:690-695, 1991.
30. Kleinjans JC, Smits JF, van Essen H, Kasbergen CM, Struyker Boudier HA. Hemodynamic characterization of hypertension induced by chronic intrarenal or intravenous infusion of norepinephrine in conscious rats. Hypertension 6:689-699, 1984.
31. Smits JF, Kleinjans JC, Janssen BJ, Struyker-Boudier HA. Characterization of hypertension induced by long-term intrarenal norepinephrine infusion in conscious rats. Clin Exp Hypertens A 1:197-209, 1987.
32. Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2:112-120, 2007.
33. Terada Y, Tomita K, Homma MK, Nonoguchi H, Yang T, Yamada T, Yuasa Y, Krebs EG, Marumo F. Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells. Kidney Int 48: 1801-1809, 1995.
34. Norman J, Badie-Dezfooly B, Nord EP, Kurtz I, Schlosser J, Chaudhari A, Fine LG. EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 253:F299-309, 1987.
35. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64:1573-1579, 2003.
36. Sundaresan PR, Fortin TL, Kelvie SL. Alpha- and beta-adrenergic receptors in proximal tubules of rat kidney. Am J Physiol 253:F848-856, 1987.
37. Yamaguchi I. Evidence for beta-adrenoceptors in rat proximal convoluted tubules. Kurume Med J 40:159-167, 1993.
38. Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ. Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci USA 86:6007-6011, 1989.
39. Harris PC, Torres VE. Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy. Curr Opin Nephrol Hypertens 15:456-463, 2006.
40. Wolf G, Neilson EG. Isoproterenol induces mitogenesis in MCT and LLC-PK1 tubular cells. J Am Soc Nephrol 4:1995-2002, 1994.
41. Chapman AL, Guay-Woodford LM, Grantham JJ et al. Renal structure in early autosomal dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int 64:1035-1045, 2003.
42. Gattone VH, Marfurt CF, Dallie S. Extrinsic innervation of the rat kidney: a retrograde tracing study. Am J Physiol 250:F189-196, 1986.